Drug (Control) Ordinance 1982

(National Drug Policy 1982)

Bangladesh Drug Market before

National Drug Policy 1982

Science Vs Profit?
Prepalin Inj. (Glaxo)

Digiplex Syp. (Fisons)

Decatone Cap. (Fisons)

Genasprin Tab. (Fisons)

Quixalin Tab. (Squibb)

Enterovioform (Ciba)

Pentids 200 Tab. (Squibb)

Novalgin (Hoechst)

Phensidyl Syp. (BPI)

Codopyrin Tab. (Glaxo)

Clinmycin Syp. (Glaxo)

Imperacin Syp. (ICI)

Vibramycin Syp. (Pfizer)

Terramycin Syp.(Pfizer)

Bangladesh Drug Market before

National Drug Policy 1982 ..........

Medicines or Wine ?
Mritosanjiboni Sura/Salsa (Ayurvedic Cos.)
Verdiviton Elixir (Squibb)
Polytamin Syp (Hoechst)
Dural Oral Tonic (Pfizer)
Nurona Syp. (KDH)
Bayers Tonic (Bayer)
Fulfords Gripe Water (Fisons)
Woodwards Gripe Water (Woodward)

Objectives of the National Drug Policy 1982

1. To ensure that the common people get the essential and
necessary drugs that are of good quality and are useful,
effective and safe.
2. To take steps to ensure that the price of the imported as
well as the locally manufactured drugs is brought within
the reach of the common people.
3. To stop in a gradual way import and manufacture of such
costly drugs as are neither essential nor required for
treatment and for which appropriate substitutes are
available.
4. To provide on a priority basis, required facilities to local
drugs manufacturing industries so that self sufficiency is
attain in the manufacture of essential drugs.
5. To prohibit the import, manufacture and sale of drugs
which have been or will be adjudged useless or injurious
by the experts. Any such drug will be immediately banned
and steps will be taken to destroy its stock.

Objectives of the National Drug Policy 1982 ...........

6. To exercise government control over advertisement so that
common people are not hood-winked by commercial
advertisement on health matters and on useless,
unnecessary and injurious drugs.
7. To exercise control on the import of drugs and raw
materials so that these are made available at reasonable
price.
8. To contract the local companies with the responsibility of
manufacturing those drugs which they can produce in
adequate quantity and to entrust the foreign companies
to gradually manufacture high quality drugs, consistent
with their ability and skill.
9. To entrust all local/foreign companies with the
responsibility of ensuring that all the essential drugs are
manufactured in the country.

Objectives of the National Drug Policy 1982 ...........

10. To ban the manufacture, sale and distribution of
adulterated and sub-standard drugs and award
exemplary punishment to persons guilty of such action.
This measure will also be applicable in the case of
Ayurvedic, Unani and Homeopathic medicines.
11. To constitute necessary number of Drug Courts to try
guilty persons and to punish them expeditiously. Such
Courts shall have at least the powers of a Sessions
Court.
12. To strengthen the system of procurement, storage and
distribution of drugs and medicines so that these are
accessible to people in all areas of the country and also
to ensure that there is no wastage of drugs in any
hospital.
13. To take gradual steps to manufacture, distribute and sell
drugs by their generic names.

Drug Import
Year

Import

1972-82
2000
2004
2010

70%
5%
3%
5%

Market Share in 1982 :

(in Tk.)
Total No. of Drug Manufacturers : 166
8 Multinationals

: 75%

25 Middle-Sized Nationals

: 15%

133 Small Nationals

: 10%

Multinationals' Market Share

1982 - 75%
2000 - 9%
2010 - 7%

Pharma Raw Materials Produced in

Bangladesh
Aluminium Hydroxide
Compressed Gel
Aluminium Hydroxide
Dried Gel
Amoxicillin
Ampicillin
Blood Transfusion Bag
Capsule Shell
Cefalexin Monohydrate
Cloxacillin
Diclofenac Sodium
Diclofenac Diethyl Amine
Ranitidine
Omeprazole
Oseltamivir

Ferrous Gluconate
Ferrous Sulphate
Flucloxacillin
Injection Syringe
Magnesium Hydroxide Paste
Magnesium Hydroxide Powder
Paracetamol
Sulphamethoxazole
Trimethoprim
Lamivudine
Zidovudine
Nelfinavir
Stavudine
Peclitexol

Drug Export from Bangladesh

2000 - 2001

: Taka 172 Crore

2001 - 2002

: Taka 225 Crore

2009 2010

: Taka 893 Crore

Bangladeshi Drugs are Now Exported to

87 Countries including ......... !!!
Argentina
Austria
Belgium
Brazil
Bulgaria
Denmark
Finland
France
Hungary
Indonesia
Jordan
Kuwait
Malaysia

Netherlands
Oman
Philippines
Poland
Qatar
Rumania
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
Venezuela
USA

Comparison of Drug Retail Prices

Amoxicillin Capsule
(100 x 250 mg)
(Amoxyl, Fisons-Beecham)

1982

2001

Tk. 718

Tk. 350

Ampicillin Capsule
Tk.
(100 x 250 mg)
(Penbritin, Fisons-Beecham)
Doxycycline Capsule
(10 x 100 mg)
(Vibramycin, Pfizer)

166

Tk. 250

Tk. 39.50 Tk. 20

US $ 1 = Taka 20.07 (in 1982), Taka 57.36 (in 2001)

Success Areas of Drug Policy 1982

1. Restriction on Unnecessary and Harmful Drugs.
2. Disciplined Manufacturing of Drug following GMP
by Making Pharmacists Legally Responsible &
Accountable.
Bangladeshi Drug Becomes Internationally Standard.
3. Control of Drug Market and More Rational Use.
Priority Not on Foreign Patented Drugs, but on
Locally Manufactured Ones.

Success Areas of Drug Policy 1982 .....

4. Patronizing Local Drug Industries to Lessen
Foreign Dependence.
Ban on Import of Drugs, Raw Materials and
Packaging Materials which are Locally
Manufactured.
5. Keeping Drug Price Stable. Import of Raw and
Packaging Materials on Competitive Basis rather
than from Designated Sources.
6. Improvement of Ayurvedic, Unani and
Homeopathic Medicines.
Modernizing Their Manufacturing and QC
Procedures.

Key Factors to Maintain This Growth

1. Market Protection by Import Prohibition of
Locally Manufactured Drugs, Raw and
Packaging Materials.
2. Pharmacists to Make for Responsible and
Accountable for Production and QC of Drugs
according to Clause 13(1) of Drug (Control)
Ordinance, 1982.
3. To Provide More Cash and Non-Cash
Incentives, Easy Income Tax Rebate and Duty
Pay-Back to Drug Exporters.

Key Factors to Maintain This Growth ..............

4. To Establish a Modern and Central QC and R&D
Laboratory in the Private Sector with Government
Assistance & Supervision.
Local Drug Industries will Share Its Installation and
Management.
This will Boost Further the Quality and Export
Potential.
5. To Develop A Drug Bio-equivalence Study InfraStructure by the Government.
Pharmacy Departments, Medical Colleges,
BIRDEM and BSMMU to Extend Technical
Support.

Thank you